Tecentriq and Avastin Liver Cancer Combo Linked to Patient Deaths in Early Trials
While some results are promising, the patient deaths are likely to spark a more thorough inquiry from the FDA before the drug combo is approved.
While some results are promising, the patient deaths are likely to spark a more thorough inquiry from the FDA before the drug combo is approved.